Results of the primary outcome measure and clinical events from the asymptomatic carotid artery progression study
- 28 September 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 76 (9) , 47C-53C
- https://doi.org/10.1016/s0002-9149(99)80470-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Pravastatin, lipids, and major coronary eventsThe American Journal of Cardiology, 1994
- Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.Circulation, 1994
- Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)Annals of Internal Medicine, 1993
- Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factorsThe American Journal of Cardiology, 1993
- Rationale and design for the asymptomatic carotid artery plaque study (ACAPS)Controlled Clinical Trials, 1992
- Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study.Stroke, 1992
- Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic HypertensionJAMA, 1991
- The cardiovascular health study: Design and rationaleAnnals of Epidemiology, 1991
- Expanded Clinical Evaluation of Lovastatin (EXCEL) Study ResultsArchives of internal medicine (1960), 1991
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988